China SXT Pharmaceuticals (SXTC) Change in Accured Expenses (2018 - 2019)

Historic Change in Accured Expenses for China SXT Pharmaceuticals (SXTC) over the last 2 years, with Q3 2019 value amounting to $701876.0.

  • China SXT Pharmaceuticals' Change in Accured Expenses rose 12326.36% to $701876.0 in Q3 2019 from the same period last year, while for Sep 2019 it was $701876.0, marking a year-over-year increase of 12326.36%. This contributed to the annual value of $298762.0 for FY2025, which is 65495.87% up from last year.
  • As of Q3 2019, China SXT Pharmaceuticals' Change in Accured Expenses stood at $701876.0, which was up 12326.36% from $691522.0 recorded in Q1 2019.
  • Over the past 5 years, China SXT Pharmaceuticals' Change in Accured Expenses peaked at $701876.0 during Q3 2019, and registered a low of $314371.0 during Q3 2018.